Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,09 NOK | -0,48% | -2,79% | -20,23% |
14/03 | Hofseth BioCare ASA kondigt bestuurswijzigingen aan | CI |
09/02 | Hofseth BioCare ASA rapporteert resultaten voor het vierde kwartaal eindigend op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 70
Verkoop per activiteit
NOK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Salmon Oil (OmeGo)
59,3
%
| 78 | 64,6 % | 129 | 59,3 % | +66,50% |
Non-soluble Protein (PetGo)
15,2
%
| 25 | 21,2 % | 33 | 15,2 % | +30,51% |
Reconciling Items
12,3
%
| - | - | 27 | 12,3 % | - |
Soluble Protein Hydrolysate (ProGo)
10,9
%
| 13 | 10,5 % | 24 | 10,9 % | +89,72% |
Calcium (CalGo)
1,2
%
| 3 | 2,4 % | 3 | 1,2 % | -10,67% |
Other
1,1
%
| 2 | 1,4 % | 2 | 1,1 % | +40,66% |
Verkoop per regio
NOK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
24,3
%
| - | - | 47 | 24,3 % | - |
France
21,1
%
| - | - | 40 | 21,1 % | - |
Belgium
13,8
%
| - | - | 26 | 13,8 % | - |
Europe excluding Norway, United Kingdom, France, Belgium
13,1
%
| 78 | 64,9 % | 25 | 13,1 % | -67,95% |
United Kingdom
10,4
%
| - | - | 20 | 10,4 % | - |
Japan
9,6
%
| - | - | 18 | 9,6 % | - |
Norway
4,7
%
| 7 | 5,8 % | 9 | 4,7 % | +30,11% |
Asia excluding Japan
3,0
%
| 14 | 11,8 % | 6 | 3,0 % | -59,23% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jon Olav Ødegård
CEO | Chief Executive Officer | 51 | 01-03-13 |
Roger Hofseth
CEO | Chief Executive Officer | 50 | 01-01-00 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 63 | 01-01-10 | |
James Berger
IRC | Investor Relations Contact | - | - |
Andy Gill
PRN | Corporate Officer/Principal | - | 01-01-21 |
Kai Morten Thuen
SAM | Sales & Marketing | - | 31-08-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roger Hofseth
CEO | Chief Executive Officer | 50 | 01-01-00 |
Director/Board Member | 53 | 01-05-15 | |
Director/Board Member | 49 | 01-05-15 | |
Amy Novogratz
BRD | Director/Board Member | - | 03-12-21 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 395 081 030 | 165 069 381 ( 41,78 %) | 0 | 41,78 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,23% | 74,77 mln. | |
-4,93% | 261 mld. | |
-2,51% | 94,98 mld. | |
+3,19% | 46,39 mld. | |
+8,74% | 39,99 mld. | |
-0,15% | 38,02 mld. | |
-16,78% | 30,16 mld. | |
-6,61% | 28,72 mld. | |
+11,32% | 24,54 mld. | |
-9,29% | 22,65 mld. |